Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma

BACKGROUND: Gliosarcoma (GSM) is a distinct and aggressive variant of glioblastoma multiforme (GBM) with worse prognosis and few treatment options. It is often managed with the same treatment modalities with temozolomide (TMZ) as in GBM. However, the therapeutic benefits on GSM from such treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiang, Karrie Mei-Yee, Chan, Andrian A., Leung, Gilberto Ka-Kit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948380/
https://www.ncbi.nlm.nih.gov/pubmed/33706745
http://dx.doi.org/10.1186/s12885-021-08008-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948380/
https://www.ncbi.nlm.nih.gov/pubmed/33706745
http://dx.doi.org/10.1186/s12885-021-08008-y

Ejemplares similares